Back to Search Start Over

Catheter based treatments for fibrosing mediastinitis.

Authors :
Fender EA
Widmer RJ
Knavel Koepsel EM
Welby JP
Kern R
Peikert T
Bjarnason H
Holmes DR Jr
Source :
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions [Catheter Cardiovasc Interv] 2019 Nov 15; Vol. 94 (6), pp. 878-885. Date of Electronic Publication: 2019 Feb 21.
Publication Year :
2019

Abstract

Fibrosing mediastinitis is a rare, often debilitating and potentially lethal disease characterized by an exuberant fibroinflammatory response within the mediastinum. Patients typically present with insidious symptoms related to compression of adjacent structures including the esophagus, heart, airways, and cardiac vessels. Fibrosing mediastinitis is most often triggered by Histoplasmosis infection; however, antifungal and anti-inflammatory therapies are largely ineffective. While structural interventions aimed at alleviating obstruction can provide significant palliation, surgical interventions are challenging with high mortality and clinical experience with percutaneous interventions is limited. Here, we will review the presentation, natural history, and treatment of fibrosing mediastinitis, placing particular emphasis on catheter-based therapies.<br /> (© 2019 Wiley Periodicals, Inc.)

Details

Language :
English
ISSN :
1522-726X
Volume :
94
Issue :
6
Database :
MEDLINE
Journal :
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
Publication Type :
Academic Journal
Accession number :
30790443
Full Text :
https://doi.org/10.1002/ccd.28152